<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00161902</url>
  </required_header>
  <id_info>
    <org_study_id>550001</org_study_id>
    <nct_id>NCT00161902</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement</brief_title>
  <official_title>A Randomized, Controlled, Multicenter Study to Evaluate Efficacy and Safety of Fibrin Sealant VH S/D for Hemostasis in Subjects Undergoing Total Hip Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baxter Healthcare Corporation</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to monitor the safety of FS VH S/D and evaluate whether FS VH S/D
      is superior to standard treatment in reducing blood loss in subjects undergoing total hip
      replacement with cement-free hip prostheses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2001</start_date>
  <completion_date>March 2003</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <condition>Hip Replacement Surgery</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fibrin Sealant Vapor-Heated Solvent/Detergent-treated</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Each subject to be included into the study must fulfill the following inclusion criteria:

          -  Subjects receiving a cement free hip prosthesis due to coxarthrosis because of primary
             or dysplastic arthrosis grade 1 – 3 according to Crowe or rheumatoid arthritis as well
             as subjects receiving a cement free hip prosthesis due to femur head necrosis (Crowe
             classification).

          -  ASA and NSAIDs have been discontinued one week prior to surgery

          -  Written informed consent

          -  Male and female at least 19 years of age

        Exclusion Criteria:

        Subjects fulfilling the following exclusion criteria will not be recruited into the study:

          -  Impaired coagulation

          -  Previous hip surgery

          -  Acetabular roof plastic

          -  Known hypersensitivity to aprotinin or other components of the product

          -  Immunodeficiency

          -  Increased red cell production

          -  Pregnant or lactating women (positive urine or serum pregnancy test; this test is
             required of any female subject who is not post menopausal or surgically sterilized).

          -  Subjects concurrently participating in another clinical trial or having received
             another investigational drug within the last 30 days.

        Also patients with abnormal coagulation values due to anticoagulants like coumadins or
        heparin must be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Florian Gottsauner-Wolf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>A. ö. Krankenhaus Krems, Austria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Axel Rüter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik für Unfall- und Wiederherstellungschirurgie des Zentralklinikums Augsburg, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>A. ö. Krankenhaus Krems, Abteilung f. Orthopädie</name>
      <address>
        <city>Krems</city>
        <state>Niederösterreich</state>
        <zip>3500</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus der Stadt Wien, University Clinic for Orthopedics</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Donauspital im SMZ Ost, Department of Orthopedic Surgery</name>
      <address>
        <city>Vienna</city>
        <zip>1220</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Unfall- u. Wiederherstellungschirurgie des Zentralklinikums Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Anna Ziekenhuis, Orthopedic Surgery</name>
      <address>
        <city>Geldrop</city>
        <zip>5664</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academisch Ziekenhuis Maastricht, Orthopedic Surgery</name>
      <address>
        <city>Maastricht</city>
        <zip>6229</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Clara Ziekenhuis, Orthopedic Surgery</name>
      <address>
        <city>Rotterdam</city>
        <zip>3078</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2005</study_first_posted>
  <last_update_submitted>October 20, 2006</last_update_submitted>
  <last_update_submitted_qc>October 20, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2006</last_update_posted>
  <keyword>Arthroplasty</keyword>
  <keyword>Hip Prosthesis</keyword>
  <keyword>Cement Free Hip Prosthesis</keyword>
  <keyword>Femur Head Necrosis</keyword>
  <keyword>Coxarthrosis</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
    <mesh_term>Fibrin Tissue Adhesive</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

